Texas Dermatology Research Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)3 trials

Phase

• Phase 33 trials

Status

• Completed3 trials

Lead sponsor

• Amgen2 trials
• Incyte Corporation1 trial

Closed trials

• Completed

  A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

  NCT06238817· Phase 3· Incyte Corporation· Source

• Completed

  A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

  NCT06224192· Phase 3· Amgen· Source

• Completed

  A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05724199· Phase 3· Amgen· Source